ARGX-113-1802: A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Grants and Contracts Details

StatusFinished
Effective start/end date6/19/22 → 3/29/24

Funding

  • PPD Investigator Services LLC: $31,564.00